Company
Denali Therapeutics Inc.
DNLI · CIK 0001714899
Sale of 1,654 shares at $22.29 per share.
Reporting Person Chin Peter Scott · Officer Title Chief Medical Officer · Transaction Code S
Traded Sep 4, 2026 · Disclosed Sep 9, 2026
Source: SEC Form 4 · 0002124755-26-000007 · filed 2026-09-09 · View filing →
Sale of 10,824 shares at $22.85 per share.
Reporting Person Thornberry Nancy · Transaction Code S
Traded Sep 2, 2026 · Disclosed Sep 4, 2026
Source: SEC Form 4 · 0001797826-26-000006 · filed 2026-09-04 · View filing →
Sale of 615 shares at $23.74 per share.
Reporting Person Thornberry Nancy · Transaction Code S
Traded Sep 2, 2026 · Disclosed Sep 4, 2026
Source: SEC Form 4 · 0001797826-26-000006 · filed 2026-09-04 · View filing →
Sale of 2,768 shares at $23.44 per share.
Reporting Person Schuth Alexander O. · Officer Title COFO and Secretary · Transaction Code S
Traded Sep 1, 2026 · Disclosed Sep 3, 2026
Source: SEC Form 4 · 0001724311-26-000014 · filed 2026-09-03 · View filing →
Sale of 2,857 shares at $25.07 per share.
Reporting Person Schuth Alexander O. · Officer Title COFO and Secretary · Transaction Code S
Traded Aug 11, 2026 · Disclosed Aug 13, 2026
Source: SEC Form 4 · 0001724311-26-000013 · filed 2026-08-13 · View filing →